Issue |
E3S Web Conf.
Volume 500, 2024
The 1st International Conference on Environment, Green Technology, and Digital Society (INTERCONNECTS 2023)
|
|
---|---|---|
Article Number | 04002 | |
Number of page(s) | 13 | |
Section | Health Science | |
DOI | https://doi.org/10.1051/e3sconf/202450004002 | |
Published online | 11 March 2024 |
From the Drugbank Application to the Novel Drugs: A Pharmacogenomic Summary
Universitas Muhammadiyah Magelang, Magelang, Indonesia
* Corresponding author: alfiansy@ummgl.ac.id
Computational drug research has grown in popularity in recent decades because to lower risks, time, cost, and resource needs as compared to traditional experimental approaches. The DrugBank application has expanded the number and quality of pharmacological activities and drug metabolic pathways depicted visually. The review elaborated a number of novel drugs and the molecular target mechanisms discovered with DrugBank. The study involves papers indexed by Scopus and Pub Med, the search uses a combination of the following keyword variants; “Drugbank AND Repurposing Drug”, “Drugbank AND Pharmacogenomic”. This study only used original articles in English that were published peer reviewed journals from October 2020 to November 2022. Thus, the screening results of library sources were narrowed to 9 original articles that met the inclusion criteria. Our result highlighted the involvement of 23 drug-targeting molecules in nine spesific diseases. The result shows 46 lists of repurposing drugs, four of which have the potential to be developed as prostate cancer treatments, five new drugs for ovarian cancer five new breast cancer drugs, eight new drugs highly recommended for depression, five candidates for atopic dermatitis, two recommended treatment for asthma, a novel drug for multiple sclerosis, and 18 potential medication for chronic hepatitis B.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.